Compare BTDR & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTDR | INSP |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2021 | 2018 |
| Metric | BTDR | INSP |
|---|---|---|
| Price | $8.04 | $69.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 16 |
| Target Price | $25.10 | ★ $102.86 |
| AVG Volume (30 Days) | ★ 7.5M | 1.2M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ 4.89 |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $89.44 | $8.70 |
| Revenue Next Year | $68.00 | $9.05 |
| P/E Ratio | ★ N/A | $12.12 |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $6.84 | $53.11 |
| 52 Week High | $27.80 | $189.49 |
| Indicator | BTDR | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 32.30 | 46.54 |
| Support Level | $7.55 | $53.11 |
| Resistance Level | $14.47 | $83.68 |
| Average True Range (ATR) | 0.88 | 5.24 |
| MACD | -0.30 | 1.16 |
| Stochastic Oscillator | 9.98 | 45.55 |
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.